Ovarian Cancer
BRAF polymorphisms not linked to ovarian cancer of low malignant potential
Published in OBGYN and Reproduction Week, September 12th, 2005
According to recent research from Australia, "The object of this study was to test the hypothesis that BRAF is a low-risk susceptibility gene for LMP ovarian cancer. A recent study of the relationship between BRAF polymorphisms and malignant melanoma identified strong linkage disequilibrium across the BRAF gene with one of the three most common haplotypes (haplotype C) having a population attributable risk of approximately 1.6%."
"We therefore hypothesized that the same BRAF haplotype may confer an increased risk of serous ovarian tumors of low...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Cervical Cancer
Successful pregnancy possible for women after vaginal radical tracelectomy - Embryonic Mutation
Hypomorphic mutation in hnRNP U results in postimplantation lethality - Hormones
Menopausal hormones and risk of ovarian cancer studied - In Vitro Fertilization
Ganirelix is safe and effective for Korean women undergoing COH for IVF - Polycystic Ovary Syndrome
Adrenal androgen excess plays role in polycystic ovary syndrome - Adverse Drug Reaction
Agency strengthens risk management program for Isotretinoin - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
